50 filings
8-K
Liquidia Corporation
18 Nov 20
Liquidia Closes Acquisition of RareGen
4:03pm
8-K
Liquidia Corporation
16 Nov 20
Liquidia Announces Results of Special Meeting of Stockholders
7:21am
8-K
Liquidia Corporation
9 Nov 20
Liquidia Reports Third Quarter 2020 Financial Results and Provides Corporate Update
7:20am
8-K
Liquidia Corporation
2 Nov 20
Liquidia Reschedules Special Meeting of Stockholders and Reaffirms Recommendation to Approve Proposed Acquisition of RareGen, LLC
8:04am
8-K
Liquidia Corporation
19 Oct 20
Liquidia Announces Postponement of Special Meeting of Stockholders
8:35am
8-K
1vfscn67x g65rw
14 Oct 20
Liquidia Provides Update on U.S. Patent Trial and Appeal Board Decision on Inter Partes Review of Two United Therapeutics’ Tyvaso® Patents
4:16pm
8-K
zos8tb ql8
20 Aug 20
Liquidia Announces Chief Financial Officer Transition
9:20am
8-K
h9cujebrkjct
10 Aug 20
Liquidia Reports Second Quarter 2020 Financial Results and Provides Corporate Update
7:20am
8-K
pe28bgux 11rhlpah
24 Jul 20
Liquidia Responds to United Therapeutics Corporation Lawsuit Alleging Infringement of New Tyvaso Patent
11:00am
8-K
xwiol9 i85lb4
2 Jul 20
Liquidia Announces Proposed Offering of Common Stock
4:30pm
8-K
nwncprrhdz3w22th6nb
29 Jun 20
Liquidia to Acquire RareGen, LLC, and Expand Presence in PAH
4:06pm
8-K
v0ez5lmabfetvnr6rnr0
19 Jun 20
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
gxl8e88s7ie 3klw7
5 Jun 20
Liquidia Responds to United Therapeutics Corporation Lawsuit Alleging Infringement of Tyvaso Patents
3:34pm
8-K
c3bag
18 May 20
Liquidia Appoints Tushar Shah, M.D., as Chief Medical Officer
4:30pm
8-K
aglupotk
11 May 20
Liquidia Reports First Quarter 2020 Financial Results and Provides Corporate Update
4:10pm
8-K
wu60pqd popd5kuof
30 Apr 20
Liquidia Releases Final LIQ861 Results from Pivotal Phase 3 INSPIRE Study in Patients with Pulmonary Arterial Hypertension
7:40am
8-K
c54x3bysag3mojhue3v
13 Apr 20
Other Events
10:19am
8-K
a0a7y m1z1a
8 Apr 20
Other Events
7:56am
8-K
i8zqmde 4irk
30 Mar 20
Other Events
4:30pm
8-K
gyvd9 ysa0
20 Mar 20
Departure of Directors or Certain Officers
4:30pm